Ignite Creation Date:
2025-12-24 @ 4:52 PM
Ignite Modification Date:
2025-12-28 @ 5:21 PM
Study NCT ID:
NCT06559150
Status:
RECRUITING
Last Update Posted:
2025-10-28
First Post:
2024-08-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis
Sponsor:
Verona Pharma plc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-09-11
Start Date Type:
ACTUAL
Primary Completion Date:
2026-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-09
Completion Date Type:
ESTIMATED
First Submit Date:
2024-08-14
First Submit QC Date:
None
Study First Post Date:
2024-08-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-24
Last Update Post Date:
2025-10-28
Last Update Post Date Type:
ESTIMATED